Indonesia permits private Covid-19 vaccination scheme

A woman receives her first dose of China's Sinovac Biotech vaccine for the coronavirus disease (Covid-19) during the mass vaccination program for the elderly people at a school in Jakarta, Indonesia, February 26, 2021. - Reuters

JAKARTA, Feb 26 (Reuters): Indonesia has authorised one of the world's first private vaccination schemes to run alongside its national programme so that companies can buy state-procured vaccines to inoculate their staff in South-East Asia's biggest country.

The initiative, approved by a government regulation, has drawn criticism from some health experts who warn it could worsen inequity.

The world's fourth most populous country has launched an ambitious programme to vaccinate 181.5 million people for free in about a year, but business had been pushing for a way of inoculating staff faster to open up the economy.

The regulation stipulates that companies can buy vaccines and inoculate staff and their families for free at privately-run health centres with vaccines distributed by state-owned pharmaceutical company Bio Farma.

The vaccines in the scheme must differ from the current rollout, which includes China's Sinovac Biotech and is slated to include the AstraZeneca and Novavax vaccines.

"The scheme cannot disturb the rollout currently done by the government," Siti Nadia Tarmizi, a senior health ministry official, told a news conference on Friday, adding there were still preparations to be made before it could start.

A Bio Farma official told the news conference that it was in talks with Moderna Inc on securing vaccines for the private scheme, a day after a minister said two million doses of China's Sinopharm vaccine had been lined up.

Vaccines for both programmes require an approval for emergency use issued by the country's food and drug agency.

A minister said this week that more than 6,600 companies had signed up for the private scheme.

Jahja Setiaatmadja, president director of Bank Central Asia , Indonesia’s biggest bank by market value, told Reuters the lender would like to secure up to 70,000 doses.

The price ceiling for vaccines will be decided by the health minister, the regulation said.

Olivia Herlinda, policy director at the Center for Indonesia's Strategic Development Initiative, a public health NGO, said the scheme could risk corruption and commercialisation and came as vaccines remained scarce.

"Private vaccination risks missing the target and opening an imbalance of access of vaccines for some groups," she said.

The government has denied risks of commercialisation and said it would work with the country's anti-graft agency during the operation's rollout. - Reuters
Article type: free
User access status:
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Aseanplus News

Asean News Headlines at 9pm on Monday (Sept 26, 2022)
NGOs urge Laos government to help rescue Malaysians held by job scam syndicate
Indonesia posts US$7.1bil Jan-Aug budget surplus, govt expects higher energy bills
Thai central bank monitoring baht weakness and no big worry yet, says its finance minister
AGC appeals against Zahid’s acquittal in VLN case
US vice-president Harris and Japan PM Kishida condemn China's actions in Taiwan Strait
Oh dear! Chapatis to cost more now in Singapore; Indian eateries in country hurt by India's wheat ban
Former TVB heartthrob Wilson Lam's daughter wins Miss Hong Kong 2022
It’s just a ‘courtesy visit’, say sources on Zahid-Hadi meeting
Philippines logs 2,001 new Covid-19 cases and 29 more deaths on Monday (Sept 26)

Others Also Read